AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLINUVEL PHARMACEUTICALS LTD

9.230

+0.0900.98%

Volume:91.11K

Turnover:843.07K

Market Cap:463.35M

PE:14.34

High:9.370

Open:9.180

Low:9.160

Close:9.140

52wk High:13.933

52wk Low:8.910

Shares:50.20M

Float Shares:41.32M

Volume Ratio:1.08

T/O Rate:0.22%

Dividend:0.05

Dividend Rate:0.54%

EPS(TTM):0.644

EPS(LYR):0.718

ROE:13.96%

ROA:10.62%

PB:1.86

PE(LYR):12.86

Loading ...

Overview Company News Filings

Clinuvel Pharmaceuticals (ASX:CUV): Valuation Check After Vallaurix Expansion to Boost Peptide Drug Development

Simply Wall St.

Is Clinuvel (ASX:CUV) Using Its Singapore Peptide Hub To Quietly Redefine Its Pipeline Ambitions?

Simply Wall St.

BRIEF-Clinuvel Pharmaceuticals Expands Singapore Rd&I Centre To Pioneer Next-Generation Peptide Therapies

BUZZ-Australia's Clinuvel jumps on expansion of Singapore R&D hub

Clinuvel Expands Research, Development Center in Singapore

MT Newswires Live

Exploring 3 High Growth Tech Stocks in Australia

Simply Wall St.

Clinuvel Confirms Mid-2026 Target to File Adrenocorticotropic Hormone Formulation Therapy Candidate with European Regulator

MT Newswires Live

High Growth Tech Stocks in Australia for November 2025

Simply Wall St.

Clinuvel Pharmaceuticals (ASX:CUV): Valuation Insights After SEC Review Delay and Share Price Dip

Simply Wall St.

Clinuvel Pharmaceuticals Expects US Shutdown to Impact ADR Program Upgrade Deadlines

MT Newswires Live

Clinuvel Pharmaceuticals Ltd-Update on Adr Upgrade, Nasdaq Uplisting

THOMSON REUTERS

Clinuvel Pharmaceuticals Ltd - Expects U.S. Shutdown to Impact SEC Review Timelines

THOMSON REUTERS

Clinuvel Pharmaceuticals Ltd - Plans Adr Upgrade to Level Ii on Nasdaq

THOMSON REUTERS

ASX Growth Companies With Insider Stakes Up To 38%

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CUV.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":9.23,"timestamp":1776319920000,"preClose":9.14,"halted":0,"volume":91112,"delay":0,"changeRate":0.009846827133479195,"nameEN":"CLINUVEL PHARMACEUTICALS LTD","floatShares":41318955,"shares":50200740,"eps":0.643659,"marketStatus":"Not Yet Opened","change":0.09,"latestTime":"04-16 16:12:00 AEST","open":9.18,"high":9.37,"low":9.16,"amount":843070,"amplitude":0.022976,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.643659,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1776384000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":9.14,"dividendRate":0.005417,"openAndCloseTimeList":[[1776297600000,1776319200000]],"volumeRatio":1.0781847233078208,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CUV.AU","preClose":9.23,"auctionPrice":9.24,"auctionVolume":223,"auctionTime":1776382031436,"referenceTime":1776335404095,"auction":1,"marketStatus":"盘前竞价","timestamp":1776382031436}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41318955,"roa":"10.62%","roe":"13.96%","lyrEps":0.717999,"volumeRatio":1.0781847233078208,"shares":50200740,"dividePrice":0.05,"high":9.37,"amplitude":0.022976,"preClose":9.14,"low":9.16,"week52Low":8.91,"pbRate":"1.86","psRate":"4.81","week52High":13.933,"institutionHeld":0,"latestPrice":9.23,"eps":0.643659,"divideRate":0.005417,"volume":91112,"delay":0,"ttmEps":0.643659,"open":9.18,"prevYearClose":12.46,"prevWeekClose":9.09,"prevMonthClose":9.89,"prevQuarterClose":9.89,"fiveDayClose":9.11,"twentyDayClose":9.75,"sixtyDayClose":12.48,"dividendPayoutRate":0.06921842705277628,"dividendFrequency":"A","dividendGrowthYears":5,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.0025824359172833843},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-09-04","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-05","defaultRemindTime":1756944000000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-05","currency":"AUD","dateTimestamp":1756908000000,"payDate":"2025-09-19"},{"date":"2025-08-28","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2025-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-06","defaultRemindTime":1725494400000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725458400000,"payDate":"2024-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUV.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590554975","title":"Clinuvel Pharmaceuticals (ASX:CUV): Valuation Check After Vallaurix Expansion to Boost Peptide Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2590554975","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590554975?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:15","pubTimestamp":1765401311,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals (ASX:CUV) is in the spotlight after unveiling a major expansion of its Vallaurix innovation hub in Singapore. The company has announced a five year push backed by the Economic Development Board to accelerate advanced peptide drug development.\nSee our latest analysis for Clinuvel Pharmaceuticals.\nThe market seems to be warming to that strategy, with a 30 day share price return of 17.15% and a 90 day gain of 21.11%. However, the five year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/clinuvel-pharmaceuticals-asxcuv-valuation-check-after-vallau","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/clinuvel-pharmaceuticals-asxcuv-valuation-check-after-vallau","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590314785","title":"Is Clinuvel (ASX:CUV) Using Its Singapore Peptide Hub To Quietly Redefine Its Pipeline Ambitions?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590314785","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590314785?lang=en_us&edition=fundamental","pubTime":"2025-12-09 17:15","pubTimestamp":1765271759,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals has recently expanded its Vallaurix research, development, and innovation hub in Singapore, backed by the Singapore Economic Development Board, to build a global center for advanced, long-acting peptide therapies and integrated formulation and analytical sciences.\nThis move strengthens Clinuvel’s push toward greater vertical integration in peptide-based medicine, aiming to speed up late-stage development programs and broaden its pipeline beyond a single flagship...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/is-clinuvel-asxcuv-using-its-singapore-peptide-hub-to-quietl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/is-clinuvel-asxcuv-using-its-singapore-peptide-hub-to-quietl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","IE00B19Z4B17.USD","IE00B66KJ199.SGD","CUV.AU","IE00B7SZL793.SGD","BK4131","BK7067","HUBG","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589802307","title":"BRIEF-Clinuvel Pharmaceuticals Expands Singapore Rd&I Centre To Pioneer Next-Generation Peptide Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2589802307","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589802307?lang=en_us&edition=fundamental","pubTime":"2025-12-08 09:01","pubTimestamp":1765155670,"startTime":"0","endTime":"0","summary":"BRIEF-Clinuvel Pharmaceuticals Expands Singapore Rd&I Centre To Pioneer Next-Generation Peptide TherapiesDec 8  - Clinuvel Pharmaceuticals Ltd CUV.AX:EXPANDS SINGAPORE RD&I CENTRE TO PIONEER NEXT-GENERATION PEPTIDE THERAPIESFurther company coverage: CUV.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XC0H1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUV.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589801107","title":"BUZZ-Australia's Clinuvel jumps on expansion of Singapore R&D hub","url":"https://stock-news.laohu8.com/highlight/detail?id=2589801107","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589801107?lang=en_us&edition=fundamental","pubTime":"2025-12-08 07:55","pubTimestamp":1765151713,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Clinuvel jumps on expansion of Singapore R&D hub** Shares of Clinuvel Pharmaceuticals CUV.AX advances 2.35% to A$12.620, their highest since December 1** Biopharma co announces signif","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nL6N3XD084:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589019568","title":"Clinuvel Expands Research, Development Center in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2589019568","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589019568?lang=en_us&edition=fundamental","pubTime":"2025-12-08 07:45","pubTimestamp":1765151147,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  expanded its Vallaurix research, development, and innovation center in Singapore with a five-year investment, supported by the Singaporean Economic Development Board, according to a Monday filing with the Australian bourse.The investment will ensure that ongoing projects in novel pharmaceutical and PhotoCosmetic formulation continue uninterrupted, the filing said.The company's shares added 2% in recent Monday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589801801","title":"Exploring 3 High Growth Tech Stocks in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2589801801","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589801801?lang=en_us&edition=fundamental","pubTime":"2025-12-08 03:05","pubTimestamp":1765134332,"startTime":"0","endTime":"0","summary":"As the Australian market experiences a tentative rise, with shares initially pointing towards gains before potential afternoon reversals, investors are closely monitoring economic indicators and broader market sentiment that could impact small-cap stocks. In this environment, identifying high-growth tech stocks involves looking for companies that can navigate these fluctuations effectively while capitalizing on technological advancements and strategic opportunities in the sector.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-cgs/cogstate-shares/news/exploring-3-high-growth-tech-stocks-in-australia-10","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cgs/cogstate-shares/news/exploring-3-high-growth-tech-stocks-in-australia-10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CUV.AU","BK7094","AYA.AU","XJO.AU","XAO.AU","BK7067","XKO.AU","CGS.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588880670","title":"Clinuvel Confirms Mid-2026 Target to File Adrenocorticotropic Hormone Formulation Therapy Candidate with European Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2588880670","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588880670?lang=en_us&edition=fundamental","pubTime":"2025-12-02 10:49","pubTimestamp":1764643778,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals (ASX:CUV) confirmed a mid-2026 target to file its NEURACTHEL Instant therapy candidate, a generic injectable adrenocorticotropic hormone formulation, with a European regulator","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581046771","title":"High Growth Tech Stocks in Australia for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581046771","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581046771?lang=en_us&edition=fundamental","pubTime":"2025-11-07 03:06","pubTimestamp":1762455965,"startTime":"0","endTime":"0","summary":"The Australian market has been navigating a period of uncertainty, with key indices fluctuating due to geopolitical events and rising inflation, while sectors like materials have shown resilience amidst these challenges. In this environment, identifying high growth tech stocks requires focusing on companies that demonstrate robust adaptability and innovation to thrive despite broader market volatility.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/high-growth-tech-stocks-in-australia-for-november-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/high-growth-tech-stocks-in-australia-for-november-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AYA.AU","XAO.AU","XJO.AU","BK7508","IFM.AU","BK7503","BK7094","CUV.AU","XKO.AU","BK7067","BK7016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581752570","title":"Clinuvel Pharmaceuticals (ASX:CUV): Valuation Insights After SEC Review Delay and Share Price Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2581752570","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581752570?lang=en_us&edition=fundamental","pubTime":"2025-11-04 19:35","pubTimestamp":1762256123,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals (ASX:CUV) shared that the ongoing U.S. Federal government shutdown is expected to slow the review and approval of its SEC filings. The company’s share price slipped following news of the delay.\nSee our latest analysis for Clinuvel Pharmaceuticals.\nClinuvel’s share price has steadily softened this year, with a 30-day share price return of -10.26% hinting at fading momentum. Ongoing SEC-related delays are adding to the pressure. The bigger picture shows a one-year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/clinuvel-pharmaceuticals-asxcuv-valuation-insights-after-sec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/clinuvel-pharmaceuticals-asxcuv-valuation-insights-after-sec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","CUV.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580230202","title":"Clinuvel Pharmaceuticals Expects US Shutdown to Impact ADR Program Upgrade Deadlines","url":"https://stock-news.laohu8.com/highlight/detail?id=2580230202","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580230202?lang=en_us&edition=fundamental","pubTime":"2025-11-03 08:39","pubTimestamp":1762130356,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  said it expects the ongoing US Federal Government shutdown to impact the deadline for the upgrade of its American Depositary Receipt Level program from level one to level two, according to a Monday filing with the Australian bourse.The US administration expects a longer turnaround time for the review and approval of the registration statements filed with the US Securities and Exchange Commission, the filing said.The review and approval are expected to be completed only after the shutdown is resolved, the filing added.Shares of the company fell nearly 1% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580323418","title":"Clinuvel Pharmaceuticals Ltd-Update on Adr Upgrade, Nasdaq Uplisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2580323418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580323418?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:52","pubTimestamp":1762123924,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE3LQXGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUV.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580234186","title":"Clinuvel Pharmaceuticals Ltd - Expects U.S. Shutdown to Impact SEC Review Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2580234186","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580234186?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:52","pubTimestamp":1762123924,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE3LQXGV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580188234","title":"Clinuvel Pharmaceuticals Ltd - Plans Adr Upgrade to Level Ii on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2580188234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580188234?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:52","pubTimestamp":1762123924,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE3LQXGV:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580353258","title":"ASX Growth Companies With Insider Stakes Up To 38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580353258","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580353258?lang=en_us&edition=fundamental","pubTime":"2025-11-03 03:08","pubTimestamp":1762110480,"startTime":"0","endTime":"0","summary":"The Australian stock market is showing resilience, with shares gaining even as U.S. markets face volatility due to ongoing trade discussions and mixed earnings reports. In this environment, growth companies with high insider ownership can be particularly appealing, as insider stakes often signal confidence in a company's future prospects amidst broader market fluctuations.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/asx-growth-companies-with-insider-stakes-up-to-38","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/asx-growth-companies-with-insider-stakes-up-to-38","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IR1.AU","WZR.AU","XJO.AU","BK4585","BK7093","BK7104","BK7036","AEF.AU","BK7508","BK7095","BK7116","BK7094","BB1.AU","BK4581","XKO.AU","XBI","3DP.AU","AV1.AU","BK7113","CUV.AU","NWF.AU","TTT.AU","XAO.AU","BK7067","BK7084","BK7016","BK7062","LABU","BK7506","LM8.AU","XLV","EIQ.AU","REG.AU","BK4588","ELS.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":54,"code":"91000000","status":"200"}]}}